Literature DB >> 3510987

Analysis of structural polypeptides of the lymphoproliferative disease virus (LPDV) of turkeys.

A Gazit, R Basri, M Ianconescu, K Perk, A Zimber, A Yaniv.   

Abstract

The polypeptide composition of the lymphoproliferative disease virus (LPDV) of turkeys was shown to comprise several polypeptides with apparent molecular weights of 76, 31, 28, 20 and 15 kDa. This polypeptide pattern is distinctly different from the protein profiles of avian leukosis viruses, reticuloendotheliosis virus, or murine leukemia viruses. Moreover, LPD virions contain 2 major structural proteins (p31 and p28), in contrast to only one major internal protein present in most other retroviruses. The 76 kDa protein was established as the major viral envelope glycoprotein. The uniqueness of the LPDV polypeptide pattern is consistent with the lack of genetic relatedness of LPDV genome to other retroviruses, establishing LPDV as a representative of a distinct group of retroviridae.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3510987     DOI: 10.1002/ijc.2910370212

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  3 in total

1.  Detection of lymphoproliferative disease virus by an enzyme-linked immunosorbent assay.

Authors:  J R Patel; R W Shilleto
Journal:  Epidemiol Infect       Date:  1987-12       Impact factor: 2.451

2.  Avian oncogenesis induced by lymphoproliferative disease virus: a neglected or emerging retroviral pathogen?

Authors:  Andrew B Allison; M Kevin Keel; Jamie E Philips; Andrew N Cartoceti; Brandon A Munk; Nicole M Nemeth; Trista I Welsh; Jesse M Thomas; James M Crum; Anne B Lichtenwalner; Aly M Fadly; Guillermo Zavala; Edward C Holmes; Justin D Brown
Journal:  Virology       Date:  2013-12-18       Impact factor: 3.616

3.  Characterisation of lymphoproliferative disease virus of turkeys. Structural polypeptides of the C-type particles.

Authors:  J R Patel; R W Shilleto
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.